Gene · 347
Papers2,410
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,410
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomics and mathematical modeling of longitudinal CSF differentiates fast versus slow ALS progression. | Ann Clin Transl Neurol | 2023 | 37646115 | PubTator, text mining | PubMed |
| Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer. | Int J Mol Sci | 2023 | 37628784 | PubTator, text mining | PubMed |
| Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer's Disease. | Antioxidants (Basel) | 2023 | 37627623 | PubTator, text mining | PubMed |
| Proteomic Analysis on Sequential Samples of Cystic Fluid Obtained from Human Brain Tumors. | Cancers (Basel) | 2023 | 37627098 | PubTator, text mining | PubMed |
| Female Gene Networks Are Expressed in Myofibroblast-Like Smooth Muscle Cells in Vulnerable Atherosclerotic Plaques. | Arterioscler Thromb Vasc Biol | 2023 | 37589136 | PubTator, text mining | PubMed |
| Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case study. | Pharmacol Rep | 2023 | 37587394 | PubTator, text mining | PubMed |
| Defining cardiac functional recovery in end-stage heart failure at single-cell resolution. | Nat Cardiovasc Res | 2023 | 37583573 | PubTator, text mining | PubMed |
| Mining Prognostic Biomarkers of Thyroid Cancer Patients Based on the Immune-Related Genes and Development of a Reliable Prognostic Risk Model. | Mediators Inflamm | 2023 | 37554551 | PubTator, text mining | PubMed |
| New insights into the role of adipocytes in pancreatic cancer progression: paving the way towards novel therapeutic targets. | Theranostics | 2023 | 37554282 | PubTator, text mining | PubMed |
| Immune gene signatures as prognostic criteria for cancer patients. | Ther Adv Med Oncol | 2023 | 37547445 | PubTator, text mining | PubMed |
| Multi-omics profiling of CSF from spinal muscular atrophy type 3 patients after nusinersen treatment: a 2-year follow-up multicenter retrospective study. | Cell Mol Life Sci | 2023 | 37543540 | PubTator, text mining | PubMed |
| MAVS signaling is required for preventing persistent chikungunya heart infection and chronic vascular tissue inflammation. | Nat Commun | 2023 | 37537212 | PubTator, text mining | PubMed |
| The Latest Developments in Using Proteomic Biomarkers from Urine and Serum for Non-Invasive Disease Diagnosis and Prognosis. | Biomark Insights | 2023 | 37528936 | PubTator, text mining | PubMed |
| Single-cell transcriptome sequencing of B-cell heterogeneity and tertiary lymphoid structure predicts breast cancer prognosis and neoadjuvant therapy efficacy. | Clin Transl Med | 2023 | 37525587 | PubTator, text mining | PubMed |
| Looking to the Future of the Role of Macrophages and Extracellular Vesicles in Neuroinflammation in ALS. | Int J Mol Sci | 2023 | 37511010 | PubTator, text mining | PubMed |
| Therapeutic Potential of EVs: Targeting Cardiovascular Diseases. | Biomedicines | 2023 | 37509546 | PubTator, text mining | PubMed |
| Integrating Proteomics and Lipidomics for Evaluating the Risk of Breast Cancer Progression: A Pilot Study. | Biomedicines | 2023 | 37509426 | PubTator, text mining | PubMed |
| MicroRNA-Based Discovery of Biomarkers, Therapeutic Targets, and Repositioning Drugs for Breast Cancer. | Cells | 2023 | 37508580 | PubTator, text mining | PubMed |
| Endosomal egress and intercellular transmission of hepatic ApoE-containing lipoproteins and its exploitation by the hepatitis C virus. | PLoS Pathog | 2023 | 37506130 | PubTator, text mining | PubMed |
| A single nuclei atlas of aging human abdominal subcutaneous white adipose tissue. | Res Sq | 2023 | 37503028 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/347/papers?page=14